The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMS 2022 | Optimal management of intermediate-fit and frail elderly patients with myeloma & refining frailty
In this discussion, Claudia Stege, MD, and Sonja Zweegman, MD, PhD, Amsterdam UMC, Amsterdam, Netherlands, comment on the management of intermediate-fit and frail elderly patients with multiple myeloma, outlining current and emerging therapeutic strategies, and comparing frailty indexes (FIs) including the simplified frailty score and the IMWG frailty score. This discussion took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
